When should cannabis be discontinued prior to a colonoscopy, and what are the recommendations for daily versus occasional users?

Cannabis Discontinuation Before Colonoscopy

For patients undergoing colonoscopy, cannabis does not need to be discontinued prior to the procedure, though screening for use is essential to anticipate higher sedation requirements. 1

Screening and Documentation

All patients should be routinely screened for cannabis use in the preoperative setting, including:

• Daily intake quantification (grams/day for dried cannabis, mg/day for CBD or THC oils)
• Frequency of use (daily vs occasional)
• Method of consumption (inhaled, edible, oil)
• Time of last use on procedure day

For patients consuming cannabis more than once daily, screen for cannabis use disorder (CUD) using validated tools like the Cannabis Use Disorder Identification Test 1.

Discontinuation Recommendations

Cannabis does NOT require discontinuation before colonoscopy. The perioperative guidelines specifically address major surgery with general anesthesia, not brief procedural sedation like colonoscopy 1.

The guideline's weaning recommendations apply only when:

• There are ≥7 days before surgery (not applicable to most colonoscopy scheduling)
• Patients consume high doses: >1.5 g/day smoked cannabis, >300 mg/day CBD oil, or >20 mg/day THC oil
• Surgery should never be delayed for cannabis weaning 1

For colonoscopy specifically, there is no evidence supporting procedure cancellation or mandatory discontinuation based on recent cannabis use 2.

Sedation Planning Considerations

Expected Sedation Requirements

Cannabis users require significantly higher propofol doses during endoscopy:

• Daily users: 0.33 mg/kg/min vs 0.18 mg/kg/min in non-users (83% increase) 3
• Cannabis use is an independent predictor of high propofol requirements (OR 1.77) 4
• Increased requirements also documented for midazolam (OR 1.57) and fentanyl 4

Practical Approach

For patients consuming >1.5 g/day smoked cannabis, >300 mg/day CBD, or >20 mg/day THC:

• Have additional sedation medications readily available
• Consider processed EEG depth monitoring if available
• Anticipate 50-80% higher propofol requirements
• Plan for additional PONV prophylaxis 1

For occasional users (<2-3 times daily):

• Standard sedation protocols are generally adequate
• Monitor closely and titrate as needed
• No specific modifications required 1

Key Distinctions by User Type

Daily/Heavy Users (>1.5 g/day or multiple times daily)

• Expect significantly higher sedation needs
• Increased risk of cannabis withdrawal syndrome if abstinent >48 hours
• Consider regional anesthesia when applicable (not relevant for colonoscopy) 1

Occasional Users (weekly or less frequent)

• Minimal impact on sedation requirements
• Standard protocols appropriate
• No discontinuation needed 3

Important Caveats

Acute intoxication (patient presenting "high") may actually decrease anesthetic requirements and prolong emergence—this is distinct from chronic use 1. Document time of last use on procedure day 1.

Inhaled cannabis users may have airway hyperreactivity, though this is rarely clinically significant for colonoscopy with moderate sedation 5.

Cardiovascular effects (tachycardia, hypertension) are possible but unlikely to cause complications during routine colonoscopy 5.

What NOT to Do

• Do not cancel or delay colonoscopy based solely on recent cannabis use 2
• Do not mandate abstinence periods for procedural sedation 1, 2
• Do not assume all cannabis users need identical management—quantify use and adjust accordingly 1

The evidence shows no clinically relevant differences in periprocedural complications or mortality in cannabis users versus non-users for endoscopic procedures 2. The primary consideration is adequate sedation dosing, not procedure cancellation.